{"filing": {"accession": "0001493152-26-019713", "cik": "0001763950", "ticker": "LTRN", "company_name": "Lantern Pharma Inc.", "form_type": "10-K/A", "filing_type": "10-K/A", "filing_date": "2026-04-30", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/1763950/000149315226019713/0001493152-26-019713-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/1763950/000149315226019713/0001493152-26-019713-index.htm", "period_of_report": "2025-12-31"}, "html_url": "/api/filings/000149315226019713/stream", "exhibits": [{"exhibit_number": "3.1", "exhibit_type": "3", "description": "(a)", "filename": "ea120601fs1ex3-1i_lantern.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000121390020009332/ea120601fs1ex3-1i_lantern.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "3.2", "exhibit_type": "3", "description": "(a)", "filename": "ea120601fs1ex3-1ii_lantern.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000121390020009332/ea120601fs1ex3-1ii_lantern.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "3.3", "exhibit_type": "3", "description": "(a)", "filename": "ea120601fs1ex3-1iii_lantern.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000121390020009332/ea120601fs1ex3-1iii_lantern.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "3.4", "exhibit_type": "3", "description": "(b)", "filename": "ea123112ex3-1iv_lantern.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000121390020015132/ea123112ex3-1iv_lantern.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "3.5", "exhibit_type": "3", "description": "(b)", "filename": "ea123112ex3-1v_lantern.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000121390020015132/ea123112ex3-1v_lantern.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "3.6", "exhibit_type": "3", "description": "(a)", "filename": "ea120601fs1ex3-1iv_lantern.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000121390020009332/ea120601fs1ex3-1iv_lantern.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "3.7", "exhibit_type": "3", "description": "(p)", "filename": "ex3-2.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000149315224021353/ex3-2.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "3.8", "exhibit_type": "3", "description": "(t)", "filename": "ex3-2.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000164117225021407/ex3-2.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "4.1", "exhibit_type": "4", "description": "(d)", "filename": "ea121606ex4-2_lanternpharma.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000121390020011747/ea121606ex4-2_lanternpharma.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.2", "exhibit_type": "4", "description": "(k)", "filename": "f10k2020ex4-3_lantern.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000121390021014576/f10k2020ex4-3_lantern.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "10.1+", "exhibit_type": "10", "description": "(l)", "filename": "ex10-1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000149315223008241/ex10-1.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.2+", "exhibit_type": "10", "description": "(m)", "filename": "formdef14a.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000149315223013927/formdef14a.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.3+", "exhibit_type": "10", "description": "(a)", "filename": "ea120601fs1ex10-2_lantern.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000121390020009332/ea120601fs1ex10-2_lantern.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.4+", "exhibit_type": "10", "description": "(f)", "filename": "ea122762ex10-3_lanternpharma.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000121390020014351/ea122762ex10-3_lanternpharma.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.5+", "exhibit_type": "10", "description": "(c)", "filename": "ea122016ex10-4_lantern.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000121390020012863/ea122016ex10-4_lantern.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.6+", "exhibit_type": "10", "description": "(o)", "filename": "ex10-6.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000149315224010302/ex10-6.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.7+", "exhibit_type": "10", "description": "(o)", "filename": "ex10-7.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000149315224010302/ex10-7.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.8+", "exhibit_type": "10", "description": "(a)", "filename": "ea120601fs1ex10-3_lantern.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000121390020009332/ea120601fs1ex10-3_lantern.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.9", "exhibit_type": "10", "description": "(u)", "filename": "ex1-1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000164117225017810/ex1-1.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.10#", "exhibit_type": "10", "description": "(a)", "filename": "ea120601fs1ex10-7_lantern.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000121390020009332/ea120601fs1ex10-7_lantern.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.11#", "exhibit_type": "10", "description": "(a)", "filename": "ea120601fs1ex10-11_lantern.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000121390020009332/ea120601fs1ex10-11_lantern.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.12#", "exhibit_type": "10", "description": "(a)", "filename": "ea120601fs1ex10-12_lantern.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1763950/000121390020009332/ea120601fs1ex10-12_lantern.htm", "category": "contracts", "incorporated_by_reference": true}], "sections": [{"section_name": "part_3", "section_title": "Part III", "start_position": 4167, "end_position": 4179}, {"section_name": "item_10", "section_title": "Directors and Executive Officers", "start_position": 4179, "end_position": 4248}, {"section_name": "item_11", "section_title": "Executive Compensation", "start_position": 4248, "end_position": 4285}, {"section_name": "item_12", "section_title": "Security Ownership", "start_position": 4285, "end_position": 4394}, {"section_name": "item_13", "section_title": "Certain Relationships", "start_position": 4394, "end_position": 4482}, {"section_name": "item_14", "section_title": "Principal Accountant Fees", "start_position": 4482, "end_position": 4539}, {"section_name": "part_4", "section_title": "Part IV", "start_position": 4539, "end_position": 65198}], "tables": [{"table_index": 0, "table_type": "text", "caption": null, "header_text": "Delaware001-3931846-3973463"}, {"table_index": 1, "table_type": "text", "caption": null, "header_text": "1920\n McKinney Avenue,7th FloorDallas,Texas75201"}, {"table_index": 2, "table_type": "text", "caption": null, "header_text": "Title\n of each classTrading\n SymbolName\n of each exchange on which registered"}, {"table_index": 3, "table_type": "text", "caption": null, "header_text": "Large\n accelerated filer\u2610Accelerated\n filer\u2610"}, {"table_index": 6, "table_type": "exhibit_index", "caption": null, "header_text": "Page"}, {"table_index": 11, "table_type": "text", "caption": null, "header_text": "NameAgePosition"}, {"table_index": 12, "table_type": "text", "caption": null, "header_text": "(a)Member\n of the Audit Committee of our Board."}, {"table_index": 17, "table_type": "text", "caption": null, "header_text": "Name and Principal PositionYearSalary($)Bonus($)Option Awards($)(1)(2)Other Compensation($)(3)Total($)"}, {"table_index": 18, "table_type": "text", "caption": null, "header_text": "(1)For\n 2025, the fair value of the options granted was estimated using the Black-Scholes option-pricing model using the following weighted\n average assumptions: term of 5.52 years, risk free rate of "}, {"table_index": 23, "table_type": "text", "caption": null, "header_text": "Plan categoryNumber of securities to be issued upon exercise of outstanding options, warrants and rightsWeighted-average exercise price of outstanding options, warrants and rightsNumber of securities "}, {"table_index": 26, "table_type": "text", "caption": null, "header_text": "Option Awards"}, {"table_index": 27, "table_type": "text", "caption": null, "header_text": "(1)The\n options vest and first become exercisable in equal monthly increments over a 24-month period commencing on the one-month anniversary\n of the date of grant."}, {"table_index": 28, "table_type": "text", "caption": null, "header_text": "NameFees Earned orPaid in Cash($)OptionAwards (2)($)Total($)"}, {"table_index": 29, "table_type": "text", "caption": null, "header_text": "(1)Dr.\n Schalop joined the Board in July 2025."}, {"table_index": 32, "table_type": "text", "caption": null, "header_text": "Shares BeneficiallyOwned"}, {"table_index": 33, "table_type": "text", "caption": null, "header_text": "*Represents\n less than 1% of shares outstanding."}, {"table_index": 36, "table_type": "financial", "caption": null, "header_text": "\u25cfthe\n amounts involved exceeded or will exceed the lesser of $120,000 or 1% of the average of our total assets at year-end for the last\n two completed fiscal years; and"}, {"table_index": 39, "table_type": "text", "caption": null, "header_text": "20252024"}, {"table_index": 40, "table_type": "text", "caption": null, "header_text": "(A)\n The audit fees consisted of fees for the audit of our financial statements, the review of the interim financial statements included\n in our quarterly reports on Form 10-Q, and other professional "}, {"table_index": 44, "table_type": "exhibit_index", "caption": null, "header_text": "Exhibit\n No.Description"}, {"table_index": 47, "table_type": "exhibit_index", "caption": null, "header_text": "10.13+(c)Employment Agreement dated May 18, 2020 with Kishor G Bhatia"}, {"table_index": 48, "table_type": "exhibit_index", "caption": null, "header_text": "(a)Incorporated\n by reference from the Registration Statement on Form S-1 filed April 16, 2020."}, {"table_index": 52, "table_type": "text", "caption": null, "header_text": "Lantern\n Pharma Inc.,"}], "exhibits_pending": true, "cdn_html": true, "response_time_ms": 30}